Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

387 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Recruiting

Combining Active and Passive DNA Hypomethylation

NCT03999723

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Herlev University Hospital Copenhagen, Denmark
View Trial Details
Enrolling by invitation

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

NCT04093570

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Compassionate Care Research Group Fountain Valley, California, United States
  • Boca Raton Clinical Research Plantation, Florida, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
View all 47 locations
View Trial Details
Active, not recruiting

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

NCT05201066

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Oregon Health Sciences University Portland, Oregon, United States
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 24 locations
View Trial Details
Active, not recruiting

Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

NCT02530034

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
Locations
  • Augusta University Augusta, Georgia, United States
  • Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details

Related conditions